2012 ICD 9 CM CHANGES – NEW DIAGNOSIS CODES Effective from October 1, 2011

The ICD 9 CM diagnosis codes w.e.f October 1 2011 includes additions in Shiga toxin producing E. coli, Neoplasm codes, Skin cancer codes (e.g., basal cell and squamous cell skin cancers), Postoperative shock, etc. A complete update of New ICD 9 CM codes has been listed below.

041.41 Shiga toxin-producing Escherichia coli [E. coli] (STEC) O157
041.42 Other specified Shiga toxin-producing Escherichia coli [E. coli] (STEC)
041.43 Shiga toxin-producing Escherichia coli [E. coli] (STEC), unspecified
041.49 Other and unspecified Escherichia coli [E. coli]
173.00 Unspecified malignant neoplasm of skin of lip
173.01 Basal cell carcinoma of skin of lip
173.02 Squamous cell carcinoma of skin of lip
173.09 Other specified malignant neoplasm of skin of lip
173.10 Unspecified malignant neoplasm of eyelid, including canthus
173.11 Basal cell carcinoma of eyelid, including canthus
173.12 Squamous cell carcinoma of eyelid, including canthus
173.19 Other specified malignant neoplasm of eyelid, including canthus
173.20 Unspecified malignant neoplasm of skin of ear and external auditory canal
173.21 Basal cell carcinoma of skin of ear and external auditory canal
173.22 Squamous cell carcinoma of skin of ear and external auditory canal
173.29 Other specified malignant neoplasm of skin of ear and external auditory canal
173.30 Unspecified malignant neoplasm of skin of other and unspecified parts of face
173.31 Basal cell carcinoma of skin of other and unspecified parts of face
173.32 Squamous cell carcinoma of skin of other and unspecified parts of face
173.39 Other specified malignant neoplasm of skin of other and unspecified parts of face
173.40 Unspecified malignant neoplasm of scalp and skin of neck
173.41 Basal cell carcinoma of scalp and skin of neck
173.42 Squamous cell carcinoma of scalp and skin of neck
173.49 Other specified malignant neoplasm of scalp and skin of neck
173.50 Unspecified malignant neoplasm of skin of trunk, except scrotum
173.51 Basal cell carcinoma of skin of trunk, except scrotum
173.52 Squamous cell carcinoma of skin of trunk, except scrotum
173.59 Other specified malignant neoplasm of skin of trunk, except scrotum
173.60 Unspecified malignant neoplasm of skin of upper limb, including shoulder
173.61 Basal cell carcinoma of skin of upper limb, including shoulder
173.62 Squamous cell carcinoma of skin of upper limb, including shoulder
173.69 Other specified malignant neoplasm of skin of upper limb, including shoulder
173.70 Unspecified malignant neoplasm of skin of lower limb, including hip
173.71 Basal cell carcinoma of skin of lower limb, including hip
173.72 Squamous cell carcinoma of skin of lower limb, including hip
173.79 Other specified malignant neoplasm of skin of lower limb, including hip
173.80 Unspecified malignant neoplasm of other specified sites of skin
173.81 Basal cell carcinoma of other specified sites of skin
173.82 Squamous cell carcinoma of other specified sites of skin
173.89 Other specified malignant neoplasm of other specified sites of skin
173.90 Unspecified malignant neoplasm of skin, site unspecified
173.91 Basal cell carcinoma of skin, site unspecified
173.92 Squamous cell carcinoma of skin, site unspecified
173.99 Other specified malignant neoplasm of skin, site unspecified
282.40 Thalassemia, unspecified
282.43 Alpha thalassemia
282.44 Beta thalassemia
282.45 Delta-beta thalassemia
282.46 Thalassemia minor
282.47 Hemoglobin E-beta thalassemia
284.11 Antineoplastic chemotherapy induced pancytopenia
284.12 Other drug-induced pancytopenia
284.19 Other pancytopenia
286.52 Acquired hemophilia
286.53 Antiphospholipid antibody with hemorrhagic disorder
286.59 Other hemorrhagic disorder due to intrinsic circulating anticoagulants, antibodies, or inhibitors
294.20 Dementia, unspecified, without behavioral disturbance
294.21 Dementia, unspecified, with behavioral disturbance
310.81 Pseudobulbar affect
310.89 Other specified nonpsychotic mental disorders following organic brain damage
331.6 Corticobasal degeneration
348.82 Brain death
358.30 Lambert-Eaton syndrome, unspecified
358.31 Lambert-Eaton syndrome in neoplastic disease
358.39 Lambert-Eaton syndrome in other diseases classified elsewhere
365.05 Open angle with borderline findings, high risk
365.06 Primary angle closure without glaucoma damage
365.70 Glaucoma stage, unspecified
365.71 Mild stage glaucoma
365.72 Moderate stage glaucoma
365.73 Severe stage glaucoma
365.74 Indeterminate stage glaucoma
379.27 Vitreomacular adhesion
414.4 Coronary atherosclerosis due to calcified coronary lesion
415.13 Saddle embolus of pulmonary artery
425.11 Hypertrophic obstructive cardiomyopathy
425.18 Other hypertrophic cardiomyopathy
444.01 Saddle embolus of abdominal aorta
444.09 Other arterial embolism and thrombosis of abdominal aorta
488.81 Influenza due to identified novel influenza A virus with pneumonia
488.82 Influenza due to identified novel influenza A virus with other respiratory manifestations
488.89 Influenza due to identified novel influenza A virus with other manifestations
508.2 Respiratory conditions due to smoke inhalation
512.2 Postoperative air leak
512.81 Primary spontaneous pneumothorax
512.82 Secondary spontaneous pneumothorax
512.83 Chronic pneumothorax
512.84 Other air leak
512.89 Other pneumothorax
516.30 Idiopathic interstitial pneumonia, not otherwise specified
516.31 Idiopathic pulmonary fibrosis
516.32 Idiopathic non-specific interstitial pneumonitis
516.33 Acute interstitial pneumonitis
516.34 Respiratory bronchiolitis interstitial lung disease
516.35 Idiopathic lymphoid interstitial pneumonia
516.36 Cryptogenic organizing pneumonia
516.37 Desquamative interstitial pneumonia
516.4 Lymphangioleiomyomatosis
516.5 Adult pulmonary Langerhans cell histiocytosis
516.61 Neuroendocrine cell hyperplasia of infancy
516.62 Pulmonary interstitial glycogenosis
516.63 Surfactant mutations of the lung
516.64 Alveolar capillary dysplasia with vein misalignment
516.69 Other interstitial lung diseases of childhood
518.51 Acute respiratory failure following trauma and surgery
518.52 Other pulmonary insufficiency, not elsewhere classified, following trauma and surgery
518.53 Acute and chronic respiratory failure following trauma and surgery
539.01 Infection due to gastric band procedure
539.09 Other complications of gastric band procedure
539.81 Infection due to other bariatric procedure
539.89 Other complications of other bariatric procedure
573.5 Hepatopulmonary syndrome
596.81 Infection of cystostomy
596.82 Mechanical complication of cystostomy
596.83 Other complication of cystostomy
596.89 Other specified disorders of bladder
629.31 Erosion of implanted vaginal mesh and other prosthetic materials to surrounding organ or tissue
629.32 Exposure of implanted vaginal mesh and other prosthetic materials into vagina
631.0 Inappropriate change in quantitative human chorionic gonadotropin (hCG) in early pregnancy
631.8 Other abnormal products of conception
649.81 Onset (spontaneous) of labor after 37 completed weeks of gestation but before 39 completed weeks gestation, with delivery by (planned) cesarean section, delivered, with or without mention of antepartum condition
649.82 Onset (spontaneous) of labor after 37 completed weeks of gestation but before 39 completed weeks gestation, with delivery by (planned) cesarean section, delivered, with mention of postpartum complication
704.41 Pilar cyst
704.42 Trichilemmal cyst
726.13 Partial tear of rotator cuff
747.31 Pulmonary artery coarctation and atresia
747.32 Pulmonary arteriovenous malformation
747.39 Other anomalies of pulmonary artery and pulmonary circulation
793.11 Solitary pulmonary nodule
793.19 Other nonspecific abnormal finding of lung field
795.51 Nonspecific reaction to tuberculin skin test without active tuberculosis
795.52 Nonspecific reaction to cell mediated immunity measurement of gamma interferon antigen response without active tuberculosis
808.44 Multiple closed pelvic fractures without disruption of pelvic circle
808.54 Multiple open pelvic fractures without disruption of pelvic circle
996.88 Complications of transplanted organ, stem cell
997.32 Postprocedural aspiration pneumonia
997.41 Retained cholelithiasis following cholecystectomy
997.49 Other digestive system complications
998.00 Postoperative shock, unspecified
998.01 Postoperative shock, cardiogenic
998.02 Postoperative shock, septic
998.09 Postoperative shock, other
999.32 Bloodstream infection due to central venous catheter
999.33 Local infection due to central venous catheter
999.34 Acute infection following transfusion, infusion, or injection of blood and blood products
999.41 Anaphylactic reaction due to administration of blood and blood products
999.42 Anaphylactic reaction due to vaccination
999.49 Anaphylactic reaction due to other serum
999.51 Other serum reaction due to administration of blood and blood products
999.52 Other serum reaction due to vaccination
999.59 Other serum reaction
V12.21 Personal history of gestational diabetes
V12.29 Personal history of other endocrine, metabolic, and immunity disorders
V12.55 Personal history of pulmonary embolism
V13.81 Personal history of anaphylaxis
V13.89 Personal history of other specified diseases
V19.11 Family history of glaucoma
V19.19 Family history of other specified eye disorder
V23.42 Pregnancy with history of ectopic pregnancy
V23.87 Pregnancy with inconclusive fetal viability
V40.31 Wandering in diseases classified elsewhere
V40.39 Other specified behavioral problem
V54.82 Aftercare following explantation of joint prosthesis
V58.68 Long term (current) use of bisphosphonates
V87.02 Contact with and (suspected) exposure to uranium
V88.21 Acquired absence of hip joint
V88.22 Acquired absence of knee joint
V88.29 Acquired absence of other joint